These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 12164324

  • 1. A case-control study of asthma death and life-threatening attack: their possible relationship with prescribed drug therapy in Japan.
    Tanihara S, Nakamura Y, Matsui T, Nishima S.
    J Epidemiol; 2002 May; 12(3):223-8. PubMed ID: 12164324
    [Abstract] [Full Text] [Related]

  • 2. Case-control study of salmeterol and near-fatal attacks of asthma.
    Williams C, Crossland L, Finnerty J, Crane J, Holgate S, Pearce N, Beasley R.
    Thorax; 1998 Jan; 53(1):7-13. PubMed ID: 9577515
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?
    Ernst P, Habbick B, Suissa S, Hemmelgarn B, Cockcroft D, Buist AS, Horwitz RI, McNutt M, Spitzer WO.
    Am Rev Respir Dis; 1993 Jul; 148(1):75-9. PubMed ID: 8100409
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Change in β2-agonist use after severe life events in adults with asthma: A population-based cohort study: Life events and bronchodilator usage among adults with asthma.
    Lietzén R, Virtanen P, Kivimäki M, Korkeila J, Suominen S, Sillanmäki L, Koskenvuo M, Vahtera J.
    J Psychosom Res; 2017 Sep; 100():46-52. PubMed ID: 28789792
    [Abstract] [Full Text] [Related]

  • 13. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity.
    Garrett JE, Lanes SF, Kolbe J, Rea HH.
    Thorax; 1996 Nov; 51(11):1093-9. PubMed ID: 8958891
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adverse effects of beta-agonists: are they clinically relevant?
    Abramson MJ, Walters J, Walters EH.
    Am J Respir Med; 2003 Nov; 2(4):287-97. PubMed ID: 14719995
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, Fitzgerald M, Bai T, Paré P.
    CMAJ; 2001 Mar 06; 164(5):625-31. PubMed ID: 11258208
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma.
    Wang MT, Skrepnek GH, Armstrong E, Sherrill DL, Harris RB, Tsai CL, Malone DC.
    Curr Med Res Opin; 2008 Mar 06; 24(3):859-67. PubMed ID: 18267052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.